Meet the Team Engineering the Future
Synthego is a pioneering force in the biotechnology industry, leveraging our expertise to deliver cutting-edge CRISPR and advanced Molecular Diagnostics solutions—all in pursuit of improved human health.
High-quality, scalable solutions for CRISPR research, molecular biology and diagnostic workflows
Accelerating cell and gene therapy with pioneering solutions
Synthego is a pioneering force in the biotechnology industry, leveraging our expertise to deliver cutting-edge CRISPR and advanced Molecular Diagnostics solutions—all in pursuit of improved human health.
Engineered Cytosine Base Editor eliminates double-strand breaks for safer, more efficient CRISPR-based therapeutics.
Rapid and accurate RNA amplification and real-time fluorescence for RNA-based diagnostics.
Bringing high fidelity and affordability to your breakthrough cell & gene therapy.
Proven GMP-grade SpCas9 nuclease for your CRISPR-based therapeutics.
Reliable DNA amplification with endpoint detection and results in minutes.
Engineered RNA polymerase, generating high yields of RNA for mRNA therapeutics.
Choosing a GMP manufacturing partner is one of the most critical decisions in your clinical development journey. That’s why we created our GMP Open House—a unique opportunity to visit our...
Base editors have promised safer CRISPR therapies, but their clinical translation has faltered owing to their off-target activity. Now, Synthego has partnered with Kactus Biosciences to commercialize AccuBase™ , an...
Synthego is expanding its core mission to accelerate life sciences research and clinical development with the launch of a comprehensive portfolio of high-performance molecular reagents. Building upon our established leadership...